Back to news

Amphenol Slides As Investors Pull Back From AI Infrastructure Names Ahead of Earnings

Investivoq PriceTracker

Amphenol Corporation (APH) is down 8.0% today. Here is some analysis on what might have caused this price movement.

Analysis: A clear company-specific catalyst is not obvious, so the move appears tied mostly to a broader selloff in AI-related and growth technology stocks. This could be because Amphenol has been a major beneficiary of AI infrastructure enthusiasm, and investors may be trimming exposure ahead of its October 28 earnings report after a strong run and premium valuation.

Details:

  • Amphenol is scheduled to report third-quarter 2026 results on October 28, putting extra focus on near-term expectations and guidance.
  • The company previously guided post-split adjusted diluted EPS for the third quarter to $0.70 to $0.71 and has highlighted strong exposure to communications, IT datacom and other high-growth interconnect markets.
  • Broader market trading on October 22 has featured renewed pressure on AI and growth stocks, which can weigh on suppliers tied to data-center and infrastructure spending even without new company headlines.
  • Amphenol shares had been trading near record levels in recent weeks after strong second-quarter results, a stock split announcement, and upbeat sentiment around AI demand, which may have left the stock vulnerable to profit-taking.
  • Sources:

    Amphenol, Yahoo Finance, AP News, SEC

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $APH Insider Trading Activity

    APH Insider Trades

    $APH insiders have traded $APH stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.

    Here’s a breakdown of recent trading of $APH stock by insiders over the last 6 months:

    • CRAIG A LAMPO (EVP& CFO) sold 193,200 shares for an estimated $32,324,156
    • DAVID M SILVERMAN (EVP, Human Resources) sold 120,000 shares for an estimated $20,908,476
    • RICHARD ADAM NORWITT (President & CEO) has made 0 purchases and 3 sales selling 130,775 shares for an estimated $18,709,065.
    • LANCE E D'AMICO (EVP, Secretary & GenCounsel) has made 0 purchases and 3 sales selling 100,000 shares for an estimated $16,190,245.

    To track insider transactions, check out Investivoq's insider trading dashboard. You can access data on insider stock transactions through the Investivoq API insider transaction endpoint.

    EARLY ACCESS
    Receive APH Data Alerts
    Real-time alerts on filings, insider trades, and market signals — before everyone else.
    Get Alerts →

    $APH Hedge Fund Activity

    We have seen 1,311 institutional investors add shares of $APH stock to their portfolio, and 935 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    • JPMORGAN CHASE & CO added 39,198,712 shares (+inf%) to their portfolio in Q2 2026, for an estimated $6,911,516,899
    • FMR LLC removed 8,908,516 shares (-11.2%) from their portfolio in Q2 2026, for an estimated $1,570,749,541
    • CAPITAL INTERNATIONAL INVESTORS added 7,702,416 shares (+21.8%) to their portfolio in Q2 2026, for an estimated $1,358,089,989
    • SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 7,441,815 shares (+inf%) to their portfolio in Q2 2026, for an estimated $1,312,140,820
    • T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 6,896,100 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $1,215,920,352
    • PRICE T ROWE ASSOCIATES INC /MD/ added 5,824,431 shares (+22.2%) to their portfolio in Q2 2026, for an estimated $1,026,963,673
    • BANK OF AMERICA CORP /DE/ removed 4,474,455 shares (-21.6%) from their portfolio in Q2 2026, for an estimated $788,935,905

    To track hedge funds' stock portfolios, check out Investivoq's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Investivoq API 13F endpoint.

    $APH Congressional Stock Trading

    Members of Congress have traded $APH stock 3 times in the past 6 months. Of those trades, 3 have been purchases and 0 have been sales.

    Here’s a breakdown of recent trading of $APH stock by members of Congress over the last 6 months:

    • REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 08/18.
    • REPRESENTATIVE DAN NEWHOUSE purchased up to $15,000 on 07/10.
    • REPRESENTATIVE RICK LARSEN purchased up to $15,000 on 07/08.

    To track congressional stock trading, check out Investivoq's congressional trading dashboard. You can access data on congressional stock trades through the Investivoq API Congress trades endpoint.

    $APH Analyst Ratings

    Wall Street analysts have issued reports on $APH in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

    Here are some recent analyst ratings:

    • Evercore ISI Group issued a "Outperform" rating on 04/30/2026

    To track analyst ratings and price targets for $APH, check out Investivoq's $APH forecast page.

    $APH Price Targets

    Multiple analysts have issued price targets for $APH recently. We have seen 7 analysts offer price targets for $APH in the last 6 months, with a median target of $185.0.

    Here are some recent targets:

    • Wamsi Mohan from B of A Securities set a target price of $185.0 on 07/09/2026
    • Joseph Spak from UBS set a target price of $185.0 on 07/09/2026
    • Guy Hardwick from Barclays set a target price of $180.0 on 05/04/2026
    • William Stein from Truist Securities set a target price of $200.0 on 04/30/2026
    • Amit Daryanani from Evercore ISI Group set a target price of $180.0 on 04/30/2026
    • Asiya Merchant from Citigroup set a target price of $180.0 on 04/30/2026
    • Samik Chatterjee from JP Morgan set a target price of $200.0 on 04/30/2026

    This article is not financial advice. See Investivoq's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.